(Q74531389)

English

Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation

scientific article published on 01 August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

lymphoproliferative disorders

1 reference

based on heuristic

inferred from title

Jesús San Miguel

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Sánchez ML

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Almeida J

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Vidriales B

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

López-Berges MC

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

García-Marcos MA

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Moro MJ

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Corrales A

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Calmuntia MJ

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Orfao A

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1460-1469

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12145686%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402584

0 references

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypical detection of minimal residual disease in acute leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of aberrant phenotypes in acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Current therapy for CLL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leuk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Redefining the therapeutic goals in chronic lymphocytic leukemia: towards an evidence-based, risk-adapted therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody therapy in lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402584

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74531389&oldid=1758306845"